Clotting disorders
Sort by:
Scripps Health
Hormonal Therapy and Thrombosis Risk in Women
FEATURING
Damon Houghton
- 13 views
- March 27, 2025
Scripps Health
Hormonal Therapy and Thrombosis Risk With Testosterone
FEATURING
Damon Houghton
- 16 views
- March 27, 2025
Scripps Health
Latest Updates on Antiphospholipid Antibodies: Background and Diagnosis
FEATURING
Stephan Moll
- 13 views
- March 27, 2025
Scripps Health
Latest Updates on Antiphospholipid Antibodies: Treatment Approach and Considerations
FEATURING
Stephan Moll
- 5 views
- March 27, 2025
The France Foundation
Hemophilia Updates: Treatment Approach for Novel Therapies - Panel Discussion
- 8 views
- February 16, 2025
The France Foundation
Hemophilia Updates: Treatment Considerations for Non-Factor and Gene Therapies - Panel Discussion
- 30 views
- February 16, 2025
- 1
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Targeted Medical Therapies for Vascular Anomalies
FEATURING
Alexandra Borst
- 35 views
- February 6, 2025
- 1
Sanofi Rare Hematology
Criteria for evaluation of appropriate aTTP treatment duration
FEATURING
Radhika Gangaraju
- 98 views
- February 4, 2025
Sanofi Rare Hematology
aTTP treatment: Treating and addressing acute episodes
FEATURING
Galia Spectre
- 118 views
- February 4, 2025
Sanofi Rare Hematology
Lessons Learned From Two Episodes in a Single Patient
FEATURING
Shruti Chaturvedi
- 92 views
- February 4, 2025
Sanofi Rare Hematology
A case study approach Redefining outcomes in aTTP
FEATURING
John-Paul Westwood
- 94 views
- February 4, 2025
Sanofi Rare Hematology
Differences in aTTP Clinical Outcomes Based on Treatment Management Decision
FEATURING
Linus A. Völker
- 91 views
- February 4, 2025
Sanofi Rare Hematology
Differences in aTTP Clinical Outcomes Based on Treatment Initiation Decision
FEATURING
María E. Mingot-Castellano
- 91 views
- February 4, 2025
Sanofi Rare Hematology
Efficacy and Safety of an aTTP Therapy in a Pivotal Trial
FEATURING
Spero Cataland
- 93 views
- February 4, 2025
Cleveland Clinic Taussig Cancer Institute
ASH 2024 Review: Advances in VTE and Cancer-Associated Thrombosis
FEATURING
Kristen Sanfilippo
- 106 views
- January 31, 2025
- 2
Cleveland Clinic Taussig Cancer Institute
ASH 2024 Review: AI in Classical Hematology
FEATURING
Rushad Patell
- 60 views
- January 31, 2025
ecancer
ASH 2024 Insights: Incidence of Thrombosis With Breast Cancer Targeted Therapies
FEATURING
James Martin
- 18 views
- January 17, 2025
Moffitt Cancer Center
Role of the PCP in ITP Management
FEATURING
Vania Phuoc
- 26 views
- January 17, 2025
Weill Cornell Medicine Oncology & Hematology
Management of Treatment-Naive ITP Patients
FEATURING
James Bussel
- 104 views
- January 8, 2025
Irina Murakhovskaya
Current Treatment Guidelines for ITP: Individualized Therapy and Emerging Strategies
- 242 views
- December 27, 2024
- 1
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Full or Reduced Dose Apixaban or Rivaroxaban for Extended VTE Management
FEATURING
Jordan Schaefer
- 485 views
- December 16, 2024
- 2
16th International Congress on Myeloproliferative Neoplasms
Hypercoagulability in MPNs: Prediction and Management
FEATURING
Craig Kessler
- 53 views
- December 10, 2024
Amy Shapiro
Type 1 Plasminogen Deficiency: Disease Overview and Evolving Management
- 84 views
- November 21, 2024
- 1